Synthesis of lipid integrim antagonist
Ended Purchase Order Awarded
- Contract number
- HHSN269200513617P
- Awardee
-
Davos Chemical Corp. UEI NZL9JLQULS15
- Awarding agency
-
Office of the Chief Operating Officer
National Institutes of Health, Department of Health and Human Services
- Obligated
- $171,500
Award facts
- Contract value 100% obligated
- $171,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- ENGLEWD CLFS, NJ 07632, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN269200513617P?
HHSN269200513617P was awarded to Davos Chemical Corp. by Office of the Chief Operating Officer (National Institutes of Health) on August 10, 2005.
How much is contract HHSN269200513617P worth?
The government has obligated $171,500 on HHSN269200513617P.
Was contract HHSN269200513617P competed?
The extent of competition for HHSN269200513617P was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award